ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
AI ML Innovations Inc (QB)

AI ML Innovations Inc (QB) (AIMLF)

0.054
0.0008
(1.50%)
Closed March 28 04:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.054
Bid
0.051
Ask
0.057
Volume
5,551
0.054 Day's Range 0.0545
0.05 52 Week Range 0.2033
Market Cap
Previous Close
0.0532
Open
0.0545
Last Trade
1000
@
0.054
Last Trade Time
Financial Volume
$ 302
VWAP
0.054411
Average Volume (3m)
71,365
Shares Outstanding
75,949,063
Dividend Yield
-
PE Ratio
-15.51
Earnings Per Share (EPS)
-0.02
Revenue
487k
Net Profit
-1.42M

About AI ML Innovations Inc (QB)

Sector
Minrls,earths-ground,treated
Industry
Minrls,earths-ground,treated
Headquarters
Calgary, Alberta, Can
Founded
1970
AI ML Innovations Inc (QB) is listed in the Minrls,earths-ground,treated sector of the OTCMarkets with ticker AIMLF. The last closing price for AI ML Innovations (QB) was $0.05. Over the last year, AI ML Innovations (QB) shares have traded in a share price range of $ 0.05 to $ 0.2033.

AI ML Innovations (QB) currently has 75,949,063 shares outstanding. The market capitalization of AI ML Innovations (QB) is $22.03 million. AI ML Innovations (QB) has a price to earnings ratio (PE ratio) of -15.51.

AIMLF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0151-21.85238784370.06910.06910.051203880.05350266CS
4-0.00204-3.640256959310.056040.080.051153740.05909871CS
120.00224.24710424710.05180.080.05713650.05204233CS
26-0.02335-30.18745959920.077350.120.051682550.05719602CS
52-0.0017-3.052064631960.05570.20330.051066650.06996959CS
156-0.5431-90.95628872890.59710.790.03591890.13427417CS
260-0.5431-90.95628872890.59710.790.03591890.13427417CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 17.21
(262.32%)
407.25k
BCGBinah Capital Group Inc
$ 18.50
(94.74%)
125.88k
PIKKidpik Corporation
$ 5.38
(64.53%)
1.14M
SVMHSRIVARU Holding Ltd
$ 0.3994
(50.72%)
267.36k
SSKNStrata Skin Sciences Inc
$ 0.66
(48.35%)
2
NCNANuCana PLC
$ 0.2405
(-21.57%)
31.28k
WAVDWaveDancer Inc
$ 2.93
(-18.61%)
10
MVLAMovella Holdings Inc
$ 0.0615
(-18.54%)
31.46k
UGROUrban Gro Inc
$ 1.48
(-18.46%)
393
INOInovio Pharmaceuticals Inc New
$ 10.65
(-18.27%)
33
KTRAKintara Therapeutics Inc
$ 0.1182
(32.07%)
9.96M
AKBAAkebia Therapeutics Inc
$ 2.63
(17.41%)
2.34M
GMDAGamida Cell Ltd
$ 0.0498
(-15.88%)
1.34M
CISSC3is Inc
$ 0.036
(-5.76%)
1.33M
PIKKidpik Corporation
$ 5.38
(64.53%)
1.14M

AIMLF Discussion

View Posts
mick mick 3 months ago
https://www.otcmarkets.com/stock/AIMLF
👍️0
mick mick 3 months ago
https://www.otcmarkets.com/stock/AIMLF
👍️0
mick mick 5 months ago
https://www.otcmarkets.com/stock/AIMLF
👍️0
mick mick 5 months ago
EYEWEAR https://www.theglobeandmail.com/investing/markets/stocks/AIMLF/pressreleases/21248620/aiml-innovations-incs-subsidiary-enters-consortium-with-ellisor-international-for-ai-powered-augmented-reality-eyewear-project/
👍️0
mick mick 5 months ago
EYEWEAR https://www.theglobeandmail.com/investing/markets/stocks/AIMLF/pressreleases/21248620/aiml-innovations-incs-subsidiary-enters-consortium-with-ellisor-international-for-ai-powered-augmented-reality-eyewear-project/
👍️0
mick mick 5 months ago
EYEWEAR https://www.theglobeandmail.com/investing/markets/stocks/AIMLF/pressreleases/21248620/aiml-innovations-incs-subsidiary-enters-consortium-with-ellisor-international-for-ai-powered-augmented-reality-eyewear-project/
👍️0
mick mick 5 months ago
Watch AI/ML Innovations (OTC: AIMLF) (CSE: AIML) NEXT SUPER STOCK Video:
https://www.wallstreetreporter.com/2022/05/31/next-super-stock-ai-ml-billion-dollar-patent/

AIMLF’s Health Gauge subsidiary, has recently been granted a patent by the
United States Patent and Trademark Office (US Patent No. 11183303),
titled "Wearable Health Monitors and Methods of Monitoring Health".

The Patent covers Cardiovascular monitoring, Predictive health analysis, Behavioral analysis and 64 other claims,
including use of multiple configurations of wearable health monitors, in conjunction with methods of analyzing bio-signals
and monitoring health metrics (via Health Gauge's AI-driven software) for the purpose of assisting the user in achieving
their personal health and wellness objectives.

AIMLF is reporting advancing growth at its portfolio company Tech2Heal, a European mental health app innovator.
Tech2Heal is positioned for explosive revenue growth
as European healthcare mandates now provide about 2,500 Euro per patient annually for mental wellness.

Tech2Heal has just signed with a French multinational manufacturer, to provide mental wellness
support to their 170,000 employees globally, and additional Enterprise contracts are in the pipeline.

Tim Daniels also updated investors on AIML’s growing pipeline of M&A opportunities in the HealthTech space, which could have a positive impact on maximizing shareholder value in coming months.

Watch AI/ML Innovations (OTC: AIMLF) (CSE: AIML) NEXT SUPER STOCK Video:
https://www.wallstreetreporter.com/2022/05/31/next-super-stock-ai-ml-billion-dollar-patent/
👍️0
mick mick 5 months ago
AI/ML Innovations (OTC: AIMLF) (CSE: AIML) Chairman, Tim Daniels: “AI/ML Holds Key Patents
for Multi-Billion Dollar Healthcare Wearables Market”

AI/ML Innovations (OTC: AIMLF), a featured presenter at Wall Street Reporter's "Next Super Stock"
investor conference series, recently updated investors on growth initiatives at AIMLF’s portfolio of
digital health businesses including HealthGauge, a wearable personal health monitoring & management system,
using Artificial Intelligence and Machine Learning, and Tech2Heal a European mental health app innovator.

Of significant interest for investors is AIMLF’s landmark patent position for wearable health monitors -
which could position AIMLF to collect licensing fees and royalties on the $13.8 Billion global
Smart Wearable Healthcare Devices (projected to reach $37.4 Billion by 2028.

Source: Verified Market Research.) AIMLF is now starting to license its technologies to health wearables companies,
and collecting royalties.

With typical royalties of 2% of gross sales,
AIMLF could potentially generate significant recurring revenues from companies infringing on
its broad patent position in the nearly $14 billion health wearables market.
Watch AI/ML Innovations (OTC: AIMLF) (CSE: AIML) NEXT SUPER STOCK Video:
https://www.wallstreetreporter.com/2022/05/31/next-super-stock-ai-ml-billion-dollar-patent/4
👍️ 1
mick mick 5 months ago
AR/AI "SmartGlasses" partnership with Luxotica has the potential for that type of explosive revenue acceleration over the next 18 month.
👍️0
mick mick 5 months ago
Paul discusses the GAME CHANGER partnership with $78 Billion EssilorLuxotica to make AR/AI Smart Glasses for Healthcare Apps.

(EssilorLuxotica makes the RayBan Meta smart glasses - and virtually all designer brand eyewear worldwide.)

Watch Paul's demo and you will begin to understand the possibilities and how $AIMLF has a potential path to $5.00 in next 18 months.
👍️0
mick mick 5 months ago
Next Super Stock $AIMLF keeps trending higher, amidst a rough market backdrop.

Technical signals for $AIMLF are BULLISH with increasing volume on rising prices.

The charts show a very wide double-bottom pattern, which gives a strong foundation to support a potential +10X. Notably, $AIMLF is trending above the 50 & 200 day moving average.

It appears $AIMLF is just one news release/catalyst away from a major breakout.

With new CEO Paul Duffy in place, $AIMLF is finally executing on it's growth strategy and upside potential.
👍️0
mick mick 5 months ago
AI/ML INNOVATIONS INC.
AI/ML Innovations’ Strategic Partner, Tech2Health, Projects
https://aiml-innovations.com/wp-content/uploads/2021/09/AIML-News-Release-July-14-2021.pdf

US$5M Revenue from its First Commercial Contracts
-3 multi-year contracts signed in the first month of operation-
- digital mental health services contracts provide access to 300,000 potential usersJuly 14, 2021 ACCESSWIRE
AI/ML Innovations Inc. (CSE: AIML) (OTCQB: AIMLF) (“AIML” or the “Company”), a company
committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address
urgent societal needs, is pleased to announce that its strategic partner, Tech2Health, a France-based global
provider of proprietary digital mental health and wellness products, has entered into commercial contracts
with three companies to provide digital mental health services to their employees and insured members.
Based on the number of individuals covered and standard industry usage rates, Tech2Health estimates that
these contracts may potentially generate an aggregate total of US$5 million of revenue over the 3-year life
of the contracts. AIML has a binding Letter of Intent to acquire a 70% undivided interest in the North
American rights to Tech2Health’s complete portfolio of products and brands, in addition to a 22.22% equity
interest in Tech2Health’s global operations.
👍️0
mick mick 5 months ago
AI / ML Innovations Inc. (AIMLF)
👍️0
mick mick 5 months ago
INTERESTING AI / ML INNOVATIONS COMPANY
👍️0

Your Recent History

Delayed Upgrade Clock